SWK (NASDAQ:SWKH) Shares Up 0.4% – What’s Next?

SWK Holdings Co. (NASDAQ:SWKH)’s share price rose 0.4% during mid-day trading on Wednesday . The company traded as high as $16.25 and last traded at $15.85. Approximately 3,815 shares changed hands during trading, a decline of 64% from the average daily volume of 10,682 shares. The stock had previously closed at $15.79.

SWK Stock Performance

The company has a quick ratio of 5.06, a current ratio of 5.06 and a debt-to-equity ratio of 0.11. The firm has a market capitalization of $193.85 million, a P/E ratio of 17.04 and a beta of 0.36. The company’s 50 day moving average is $16.60 and its 200-day moving average is $16.93.

Institutional Investors Weigh In On SWK

A number of hedge funds have recently added to or reduced their stakes in SWKH. Barclays PLC raised its holdings in shares of SWK by 185.0% in the 3rd quarter. Barclays PLC now owns 4,461 shares of the company’s stock worth $77,000 after acquiring an additional 2,896 shares during the last quarter. Bank of New York Mellon Corp bought a new stake in SWK during the 2nd quarter worth approximately $172,000. Dimensional Fund Advisors LP raised its stake in shares of SWK by 85.7% in the second quarter. Dimensional Fund Advisors LP now owns 30,109 shares of the company’s stock worth $511,000 after purchasing an additional 13,892 shares during the last quarter. SkyView Investment Advisors LLC lifted its holdings in shares of SWK by 7.7% in the second quarter. SkyView Investment Advisors LLC now owns 31,165 shares of the company’s stock valued at $529,000 after purchasing an additional 2,234 shares in the last quarter. Finally, Victory Capital Management Inc. purchased a new position in shares of SWK during the third quarter valued at approximately $589,000. Institutional investors and hedge funds own 99.27% of the company’s stock.

SWK Company Profile

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.